What Pall Corp. Can Do to Take Its Shares Higher

Pall is an attractive company, but its valuation looks a little stretched. Here is what it needs to do to go higher, and a look at what rivals 3M and Donaldson are saying about the industry.

Jun 11, 2014 at 10:36AM

Pall (NYSE:PLL) presents one of the most compelling investment propositions in the industrial sector. The filtration and separation company's operations span a wide range of industries, where it competes with companies such as 3M (NYSE:MMM) and Donaldson (NYSE:DCI). However, with the stock trading on 29 times current earnings, it's hard not to conclude that much of the good news is already in the price. With that said, what  can Pall do to take the stock higher?  

A nice mix of stability and growth
The interesting thing about Pall is its combination of earnings drivers that ensure it can generate operating income through the economic cycle. The company operates out of two operating segments. The life science segment generates underlying demand from throughput activity in relatively stable industries such as pharmaceutical production. Meanwhile, the industrial segment is more focused in cyclical industries such as aerospace, microelectronics, and process.

A quick look at its segmental revenue (broken down into industry groupings) shows its life science segment has done relatively better than the industrial segment in recent years -- which is  to be expected given the sluggish global economic recovery. The life sciences end market is in blue with dotted lines. I'm focusing on consumable sales, rather than systems, because they made up nearly 89% of sales in the last quarter and tend to be higher margin.

Source: Pall Corp. presentations

The shift in revenue over the years means that life sciences contributed 49.4% of segmental revenue in 2013, up from 47% in 2011. Moreover, since the life science segment tends to have higher a profit margin than the industrial business (24.4% versus 16%  in 2013), its growth led to it contribute nearly 60% of segmental profit last year.

While the life sciences segment has clearly taken over the workload from the industrial segment in recent years, the latter will need to make a greater contribution in order for the stock to go higher.

Pall's industrial segment set for better days
Fast-forward to Pall's latest third-quarter results, and a familiar refrain is being played out, with life science consumable sales growing 9.9% at constant currency and industrial consumable sales only growing 1%.

End Market Q3 Consumable Sales (k) Q3 Constant Currency Change
Biopharmaceuticals 235,724 12.0%
Food & Beverage 46,097 8.4%
Medical 56,212 2.9%
Process Technology 137,348 (0.4)%
Aerospace 54,088 (13.4)%
Microelectronics 74,403 17.5%

Source: Pall presentations

Biopharmaceuticals continues to be the standout performer, but its food and beverage sales are improving. Indeed, Pall competes with 3M in the biopharmaceuticals and food and beverage markets, and 3M reported that 3M Purification saw "strong double-digit organic growth" in its latest quarter. It's reasonable to expect Pall's life science segment to continue to generate good growth.

Moreover, there are some signs that the industrial segment is going to see better conditions in future, too.

First, the industrial segment's orders grew 9% in the third quarter, with consumables orders up 10% -- a sure sign of future growth. Second, microelectronics sales remain strong and have bounced back from the year-over-year declines demonstrated in the first chart above.

Third, aerospace sales continue to struggle against tough comparisons from last year, and with ongoing declines in military flight hours. Indeed, Pall rival Donaldson also reported weakness in aerospace in its third-quarter results. In fact, Donaldson reduced its guidance on aerospace, as defense sales declined faster than expected, but COO Tod Carpenter also said defense "should be stabilizing at current levels." In addition, aerospace-focused Precision Castparts recently said it saw its military spares business improving in the second half.

The fourth indicator is somewhat open to debate. The process technology end market continues to be subject to disappointment, and Pall management was straightforward in highlighting that its customers still weren't aggressively undertaking capital expenditure expansion plans. Donaldson management delivered a similar message, noting "dampened and delayed capital investments and capacity expansions by our customers." Moreover, a company with a significant exposure process technology, Emerson Electric, also sounded a cautious tone on current spending. On a more positive note, Emerson also said its process customers increased orders by 9% in this past quarter, so it appears that there could be some pent-up spending about to be released in future quarters. If so, it's good news for Pall, too.

The takeaway
All told, Pall Corp needs to see business increase in its industrial segment in order for the stock to move higher, and there are some tentative signs that this will happen.


PLL EV to EBITDA (TTM) data by YCharts.

It's hard to argue that the stock is a good value right now, and there are probably cheaper ways to play a recovery in process technology spending, but momentum stocks sometimes have a life of their own. Don't be surprised if an improving industrial environment takes shares higher. 

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Lee Samaha has no position in any stocks mentioned. The Motley Fool recommends 3M. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information